天域生物
(603717)
| 流通市值：17.47亿 | | | 总市值：17.47亿 |
| 流通股本：2.90亿 | | | 总股本：2.90亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 350,661,138.6 | 153,901,746.67 | 725,588,873.17 | 535,601,036.79 |
| 营业总成本 | 398,188,983.82 | 173,927,518.76 | 835,851,001.34 | 567,048,150.94 |
| 其他经营收益 | | | | |
| 营业利润 | -51,094,099.97 | -6,639,605.16 | -101,905,573.15 | 4,312,882.49 |
| 利润总额 | -49,045,514.3 | -6,825,500.94 | -96,228,642.18 | 13,461,512.93 |
| 净利润 | -51,610,011.63 | -6,628,521.08 | -102,015,606.15 | 10,668,058.84 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | -51,610,011.63 | -6,628,521.08 | -102,015,606.15 | 10,668,058.84 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,161,224,845.24 | 1,075,618,474.65 | 1,126,478,959.03 | 1,295,638,340.86 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,694,440,016.5 | 1,793,605,354.67 | 1,766,659,652.19 | 1,698,023,144.6 |
| 资产总计 | 2,855,664,861.74 | 2,869,223,829.32 | 2,893,138,611.22 | 2,993,661,485.46 |
| 流动负债: | | | | |
| 流动负债合计 | 1,291,406,002.39 | 1,213,710,673.57 | 1,325,629,068.66 | 1,272,865,283.05 |
| 非流动负债: | | | | |
| 非流动负债合计 | 1,021,320,718.9 | 1,067,609,433.97 | 973,867,299.7 | 1,014,470,294.56 |
| 负债合计 | 2,312,726,721.29 | 2,281,320,107.54 | 2,299,496,368.36 | 2,287,335,577.61 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 338,832,938.83 | 382,458,667.3 | 412,422,762.34 | 517,715,741.11 |
| 股东权益合计 | 542,938,140.45 | 587,903,721.78 | 593,642,242.86 | 706,325,907.85 |
| 负债和股东权益合计 | 2,855,664,861.74 | 2,869,223,829.32 | 2,893,138,611.22 | 2,993,661,485.46 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 425,761,759.69 | 217,849,515.6 | 1,100,671,177 | 765,216,638.76 |
| 经营活动现金流出小计 | 431,048,018.79 | 259,219,019.84 | 842,373,474.39 | 618,005,101.93 |
| 经营活动产生的现金流量净额 | -5,286,259.1 | -41,369,504.24 | 258,297,702.61 | 147,211,536.83 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 46,910,718.46 | 32,496,407.33 | 12,736,187.52 | 1,559,230.52 |
| 投资活动现金流出小计 | 55,667,366.78 | 21,305,815.43 | 135,694,118.47 | 69,023,006.33 |
| 投资活动产生的现金流量净额 | -8,756,648.32 | 11,190,591.9 | -122,957,930.95 | -67,463,775.81 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 202,256,878.26 | 170,660,969.04 | 338,871,450.42 | 205,718,543.42 |
| 筹资活动现金流出小计 | 218,236,097.46 | 156,540,137.02 | 483,594,101.04 | 307,124,565.1 |
| 筹资活动产生的现金流量净额 | -15,979,219.2 | 14,120,832.02 | -144,722,650.62 | -101,406,021.68 |
| 汇率变动对现金及现金等价物的影响 | -51,616.43 | 4,242.16 | 57,484.8 | 72,474.66 |
| 现金及现金等价物净增加额 | -30,073,743.05 | -16,053,838.16 | -9,325,394.16 | -21,585,786 |
| 期末现金及现金等价物余额 | 60,868,055.11 | 74,887,960 | 90,941,798.16 | 78,681,406.32 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -30,073,743.05 | - | -9,325,394.16 | - |